DISCLAIMER RECOMMENDED CITATION
|
|
- Allen Jordan
- 6 years ago
- Views:
Transcription
1 DISCLAIMER This paper was submitted to the Bulletin of the World Health Organization and was posted to the Zika open site, according to the protocol for public health emergencies for international concern as described in Christopher Dye et al. ( The information herein is available for unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited as indicated by the Creative Commons Attribution 3.0 Intergovernmental Organizations licence (CC BY IGO 3.0). RECOMMENDED CITATION Yung CF, Tam CC, Rajadurai VS, Chan JKY, Low MSF, Ng YH et al. Rapid assessment of Zika virus knowledge among clinical specialists in Singapore: a cross-sectional survey [Submitted]. Bull World Health Organ. E-pub: 05 Aug doi: Rapid assessment of Zika virus knowledge among clinical specialists in Singapore: a cross-sectional survey Chee Fu Yung, a Clarence C Tam, b Victor S Rajadurai, c Jerry KY Chan, d Mabel SF Low, b Yong Hong Ng, e Koh Cheng Thoon, a Lay Kok Tan f a Infectious Disease Service, Department of Paediatrics, KK Women s and Children s Hospital, Singapore b Saw Swee Hock School of Public Health National University of Singapore, 12 Science Drive 2, Singapore c Department of Neonatology, KK Women s and Children s Hospital, Singapore d Department of Reproductive Medicine, KK Women s and Children s Hospital, Singapore e Nephrology Service, Department of Paediatrics, KK Women s and Children s Hospital, Singapore f Department of Obstetrics & Gynaecology, Singapore General Hospital, Singapore Correspondence to Clarence Tam ( clarence_tam@nuhs.edu.sg) (Submitted:4 August 2016 Published online: 5 August 2016) Page 1 of 15
2 Abstract Objective We report the results of a rapid assessment of Zika virus awareness among key clinical specialties in Singapore. Methods Between June 6 and June 19, 2016 we conducted an online survey of doctors working in obstetrics and gynaecology, neonatology and paediatrics in Singapore. The survey included 15 multiple choice questions to measure respondents' knowledge of Zika virus in four domains covering clinical and public health. Findings A total of 110 survey responses (15% response rate) were obtained, 82% of respondents worked in the public sector. Overall, the median respondent score was 9.4 (Max score=15), with substantial variation (range: ). Microcephaly and Guillain-Barré syndrome were recognised as causal complications of Zika virus infection by 99% and 50% of respondents respectively. Clinical features which could help differentiate Zika from Dengue were less well understood with 50% and 68% correctly identifying conjunctivitis and low grade fever respectively. Worryingly, 14% favoured non-steroidal anti-inflammatory drugs as part of treatment, without first excluding dengue as a diagnosis. Also, only 36% of respondents were aware of the current recommendation for preventing sexual transmission of Zika virus. Fewer than 50% were aware of the need for ophthalmological evaluation as part of congenital Zika virus infection. Conclusion Our assessment demonstrates that there is good awareness of the clinical manifestation of Zika virus disease among key specialty doctors, but confusion with Dengue disease remains. It also highlights knowledge gaps in the prevention of sexually-transmitted Zika virus infection and the clinical management of congenital Zika virus infection in newborns. Our study identified strategic areas to improve communication to front-line doctors during public health response to the Zika epidemic. What was already known about the topic concerned? Since the PHEIC declaration, guidelines for the testing and clinical management of Zika virus disease and associated complications have been issued and repeatedly updated by WHO and the US Centers for Disease Control (CDC). The fast-changing nature of the epidemic and evolving knowledge base present challenges in public health communication to front-line clinicians. To date there has not been an evaluation of Zika virus awareness and knowledge levels amongst doctors from key specialties managing patients likely to be affected by Zika virus. As many uncertainties remain, doctors need to be equipped with the latest information to minimize anxiety and ensure patients are properly informed to make difficult decisions in the management of Zika virus disease. What new knowledge the manuscript contributes? Our rapid assessment identified good levels of Zika virus disease knowledge among key specialty doctors in Singapore. Knowledge levels in lower-income countries with limited public health systems and access to information via the internet may be much lower for Page 2 of 15
3 such a rapidly-evolving epidemic. We have identified specific key areas for targeted improvements when communicating Zika virus disease knowledge to frontline doctors. We recommend that future guidelines emphasise clinical signs and symptoms which differentiate Zika virus disease from similar conditions such as dengue, particularly in countries with endemic dengue virus transmission. Similarly, greater emphasis in information sources on not using NSAIDS as a treatment option unless dengue has been excluded is also needed. There is an urgent requirement to improve doctor s knowledge on the need to advice at risk patients to practise safe sex or abstain from sexual intercourse for the duration of the pregnancy. In addition, there is a need to better educate doctors in the key specialties regarding the need for ophthalmic evaluations in congenital Zika virus infection as well as the appropriate use of Zika virus diagnostic tests and their current limitations. Page 3 of 15
4 Introduction On February 1, 2016, the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) in relation to the then suspected association between Zika virus infection and microcephaly (1). A causal association between Zika virus infection and microcephaly (2 4), and other neurological complications such as Guillain-Barré syndrome (GBS) (5, 6), has since been established on the basis of accumulating clinical and epidemiological evidence. Although the epidemic of microcephaly has been primarily focused in the northeastern part of Brazil, widespread international travel, the expansive geographic range of the Zika virus vectors, Aedes aegypti and Aedes albopictus, and increasing evidence of the potential for Zika virus transmission through sexual contact, means that spread of Zika virus and associated complications to new regions is of global concern. To date, 60 countries report ongoing mosquito-borne transmission of Zika virus, while microcephaly and other central nervous system malformations putatively associated with Zika virus infection have been reported from 11 countries (7). In three of these, microcephaly has been reported in foetuses or infants of mothers with a recent history of travel to a Zikaaffected country. Singapore, a tropical country with extensive international travel links, established Aedes mosquito populations and year-round, endemic transmission of dengue and chikungunya virus, is at potentially high-risk for introduction of Zika virus. The first imported case of Zika virus was reported in May 13, 2016 in a 48 year-old man who had recently returned from Sao Paulo, Brazil. Imported cases have also been reported in neighbouring countries with the potential to support autochthonous Zika virus transmission, and previous circulation of Zika virus has been documented in other nearby countries, including Cambodia, Thailand and Lao People's Democratic Republic.(8) Since the PHEIC declaration, guidelines for the testing and clinical management of Zika virus disease and associated complications have been issued and repeatedly updated by WHO and the US Centers for Disease Control (CDC). In Singapore, the Ministry of Health (MOH) has sent out three information updates via as well as letters to all registered doctors as of June 1, 2016, which included public health information such as mandating the notification of suspected Zika virus disease and interim clinical management guidelines for Zika virus disease in pregnant women. Mass media and information access in Singapore are easily and conveniently accessible. As a dengue-endemic country, the risk of a Zika epidemic occurring has been reported by local media and the government. Medical practitioners are familiar with accessing information via the internet, including US CDC and WHO websites. Therefore, levels of Zika virus awareness among medical practitioners in Singapore should be representative of a standard that is realistically achievable in high-income countries as well as lower-resource settings with similar infrastructure for disseminating and receiving health information. We report the results of a rapid assessment of Zika virus awareness among key clinical specialties in Singapore, with the aim of identifying gaps in knowledge and opportunities for improving communication on Zika virus disease management and control policies. Page 4 of 15
5 Methods Study participants and sites Between June 6 and June 19, 2016 we conducted an online survey of doctors working in obstetrics and gynaecology, neonatology and paediatrics in Singapore. A link to the online survey was disseminated by to the relevant doctors at KK women s and Children s Hospital and Singapore General Hospital, two large public hospitals in Singapore. Together they cater for approximately 50% of women s and children s hospital care in Singapore. To capture responses from doctors working in the private sector, the survey was also sent to members of the Obstetrics and Gynaecology Society of Singapore and the College of Paediatrics and Child Health, Singapore. The survey was anonymous and could be completed in about 10 minutes on a computer or mobile device. In order to make the survey educational, respondents were given a summary of relevant recommendations after they responded to each question. Respondents did not receive any incentive to complete the survey. Data collection The survey included 5 questions regarding respondents' age group, sex, primary specialty, professional designation (Registrar/Resident, Associate Consultant or Consultant/Senior Consultant) and practice setting (public or private sector). In addition, 15 multiple choice questions were included to measure respondents' knowledge of Zika virus in four domains: (1) Clinical Presentation, Diagnosis and Management; (2) Transmission and Prevention; (3) Clinical Management of Pregnant Mothers Potentially Infected with Zika and Infants with Microcephaly; and (4) Ministry of Health Requirements for Notification of Suspected Zika Virus Infection. Of necessity, the survey was not an exhaustive set of questions, but was designed to capture general awareness of key knowledge and guidelines under these four domains. Respondents had to provide a response to every question in order to complete the survey. Data analysis We summarized correct responses to each question using frequencies and percentages. In addition, survey responses were given a score of 0 to 15 based on the number of questions that were answered correctly. For some questions, respondents could choose more than one option (e.g. "Which types of mosquitoes are known to transmit Zika virus?"), so each question contributed a maximum of 1 mark to the total score, weighted by the number of possible correct options for that question. Scores were computed overall and for each of the four questionnaire domains. To compare levels of knowledge across domains, we normalised scores for each domain by dividing each respondent's score by the maximum possible score for that domain, such that scores for each domain were scaled betwen 0 and 1. We summarized score distributions using the median, range and interquartile range, and compared scores between categories of respondent age group, sex, medical specialty, professional designation and public/private practice using boxplots and the Kruskal-Wallis test. Response rates were estimated using the number of addresses the survey link was sent to as the denominator. Approval for this study was obtained from the SingHealth Centralised Institutional Review Board (application number 2016/2251). Page 5 of 15
6 Results A total of 110 survey responses were obtained from ing the survey to 747 doctors working in the key specialties of obstetrics and gynaecology, neonatology and paediatrics in Singapore. This represented an overall response rate of about 15%. Respondent characteristics are presented in Table 1. Approximately two-thirds of respondents were female which is consistent with the gender distribution of doctors in the participating specialties, and 56% were aged 30 to 49 years; Residents and Registrars made up half the sample and 82% of respondents worked in the public sector. Neonatology was the most common specialty among respondents (56%). Clinical Presentation, Diagnosis and Management Low-grade fever, rash and muscle or joint pain were each identified as typical symptoms of Zika virus disease by over 68% of respondents; fewer than 50% recognised conjunctivitis as part of the typical clinical presentation. Although signs of haemorrhage/bleeding and high-grade fever are not classical presentations of Zika virus disease, 6% and 37% of respondents respectively selected these. Microcephaly and GBS were recognised as a causal complications of Zika virus infection by 99% and 50% of respondents respectively. The majority of respondents recognised blood (83%) and urine (48%) as primary and secondary samples for Zika virus testing. However, while 67% were aware that polymerase chain reaction (PCR) should be the first-line test for Zika virus identification within the first week of fever onset, 20% stated that both PCR and serology would be expected to be positive. In addition, 29% believed PCR and 40% believed both PCR and serology would also be expected to be positive beyond one week. Nearly all respondents mentioned fever relief medication and fluid rehydration for management of Zika virus disease, but 14% favoured non-steroidal anti-inflammatory drugs, which are generally not recommended without first excluding dengue as a diagnosis. Clinical management of pregnant mothers potentially infected with Zika and infants with microcephaly 82% correctly identified CDC's recommendation to test infants (or cord serum) for Zika virus, but only 16% recognized the need to additionally test for dengue virus. 42% believed specific testing of infant cerebrospinal fluid (CSF) for Zika virus was warranted; CDC guidelines indicate that CSF should be tested only if collected for other purposes (9). In addition, while 94% of respondents knew that cranial ultrasound was indicated for infants with suspected congenital Zika virus infection, only 57% recognised the need to test for other infections such as rubella, syphilis, toxoplasmosis and cytomegalovirus. Fewer than 50% were aware of the recommendation for ophthalmological evaluation within 1 month after birth. Page 6 of 15
7 Transmission and prevention Most respondents (85%) identified Aedes aegypti as a mosquito vector for Zika virus, but only 32% knew that Aedes albopictus can also transmit the virus. Sexual contact and blood transfusion were recognised as alternative routes of transmission by 75% and 48% of respondents respectively, but 19% and 16% incorrectly mentioned droplet spread and saliva as transmission modes, and 34% mentioned breastfeeding. Nearly all respondents were aware of personal measures to avoid Aedes mosquite bites among pregnant women travellers, such as use of insect repellent and wearing longsleeved clothing. However, there were misconceptions regarding the location and timing of Aedes biting activity; 58% would incorrectly recommend staying away from beaches or forested areas and 47% would incorrectly recommend travellers to avoid going outdoors at night. Only 36% of respondents were aware of the current recommendation for pregnant women and their partners returning from Zika-affected areas to abstain from sexual intercourse or use condoms appropriately throughout the duration of the pregnancy. Ministry of Health Requirements for Notification of Suspected Zika Virus Infection Among respondents, 81% were aware of the need to notify suspected cases of Zika virus disease even in the absence of microbiological confirmation, but there was lack of clarity regarding the definition of a suspected case of Zika virus disease; only 22% of respondents were able to correctly identify local MOH's definition of possible exposure to Zika virus. Domain-level knowledge Overall, the median respondent score was 9.4, with substantial variation (range: ). Compared with the Clinical Presentation, Diagnosis and Management domain, median normalised scores were lower for domains on Transmission and Prevention (p<0.001) and Clinical Management of Pregnant Mothers Potentially Infected with Zika and Infants with Microcephaly (p<0.001) (Figure 1). There was no evidence of difference in scores by medical specialty, professional designation, respondent sex or age group, although statistical power for subgroup comparisons was low. Discussion To our knowledge, this was the first such rapid assessment of key clinical specialty awareness of Zika virus disease guidelines at a national level globally. Our assessment demonstrated that there was good awareness of Zika virus disease signs and symptoms among doctors, but highlighted gaps in awareness of certain recommendations, particularly ones referring to the prevention of sexually-transmitted Zika virus infection in pregnant women, and the management of infants with possible congenital Zika virus disease. Our study identified opportunities for targeted improvement of communication around Zika virus guidelines among front-line doctors. There was a high level of awareness among our sample of doctors with regards to three of the four common signs and symptoms of Zika virus disease. These three signs and symptoms are similar to those for dengue, which is endemic in Singapore. It was likely that the numerous public health and educational campaigns on dengue may have aided the translation of clinical dengue knowledge to Zika virus disease. This could also Page 7 of 15
8 explain the lack of awareness that conjunctivitis, which is less common in dengue cases, is an important distinguishing clinical feature of Zika virus disease. Similarly, 35% of respondents incorrectly chose high-grade fever as a feature of Zika virus disease. These findings suggest that while knowledge of signs and symptoms of Zika virus disease that are similar to dengue may be good, there remains a gap in understanding of clinical features that could help differentiate Zika virus disease from dengue. This is not surprising since most information outlets have repeatedly reported the similarities between the Zika and dengue viruses, which belong to the same flaviviridae virus family and share common mosquito vectors. Furthermore, messages issued by most public health bodies to clinicians provide standard case definitions that do not highlight the distinguishing features of Zika virus disease. There may be a need to change the way such messages are conveyed, with more emphasis given to differentiation rather than a standard listing of signs and symptoms. We detected similar confusion in the clinical management of Zika virus disease that could be attributed to its perceived similarity to dengue. While >85% of respondents correctly stated fever relief medication and fluid rehydration as the main treatment options, a small minority (7%) wrongly chose platelet transfusion as a possible treatment for Zika virus disease. Worryingly, 13% stated that they would consider NSAIDS for managing Zika virus disease. This is not routinely recommended, as consumption of NSAIDS could have grave consequences if a patient with dengue was misdiagnosed as having Zika virus disease. When stratified by medical specialty, the highest percentage selecting this option worked in Obstetrics and Gynaecology (23%). We were not able to exclude the possibility that the respondents who selected this option were aware of the need to exclude dengue before prescribing NSAIDs. Two-thirds of respondents knew that PCR would likely to be positive during the first few days of disease onset, but one-fifth wrongly stated that both PCR and serology testing would be positive. In a follow-up question with a more complicated scenario involving disease onset more than 8 days ago, 40% stated that both PCR and serology would be expected to be positive, while 25% wrongly selected PCR as the test of choice. Taken together, these findings suggest there is a need to improve the level of understanding for Zika virus disease diagnostics. Understanding the utility of PCR and serology in relation to the onset of symptoms is critical to minimise the potential for false positive and false negative diagnoses (10). This technical understanding is needed when developing follow-up management plans for patients. It is also fundamental in helping to effectively communicate the uncertainties of laboratory results to concerned patients. Nearly all respondents correctly identified microcephaly as a condition linked to Zika virus disease. However, only 50% were aware of the confirmed link with GBS. (5,6) This may be due to the fact that our sample s medical specialties were related to foetal, infant and paediatric patients, for which microcephaly is a key area of interest. However, 27% also stated incorrectly that small-for-gestational age (SGA) was also linked to Zika virus disease. Although microcephaly presenting with SGA can occur due to other causes, current data on Zika microcephaly points to a more targeted neurotropic effect preferentially affecting tissues of the brain and brain stem (11). Our analysis also points to gaps in knowledge regarding recommendations to prevent Zika virus infection in pregnant women. In particular, only one third of respondents Page 8 of 15
9 were aware of the current guidelines recommending that pregnant women and their partners returning from Zika-affected areas practise safe sex or abstain from sexual intercourse for the duration of the pregnancy. It was reassuring to find that a high proportion of doctors (>90%) gave correct advice in terms of recommending the use of repellants and long-sleeved clothing to minimize the risk of mosquito bites. However, about half of respondents had misconceptions regarding biting behaviour of Aedes vectors, such as preference for night biting or beach/forest settings. This was surprising considering the numerous dengue education campaigns implemented by the authorities in Singapore, although the focus of these campaigns has been primarily on source eradication to prevent mosquito breeding (12). Limitations We intentionally targeted the survey only at the clinical specialties of obstetrics and gynaecology, neonatology and paediatrics since the nature of the Zika epidemic was most relevant to their patient cohort. Furthermore, in Singapore, pregnant mothers are routinely managed and followed up by obstetricians rather than primary care physicians. Therefore, our results should be considered best case scenarios in terms of knowledge levels amongst doctors. We chose to conduct an online survey as this is a rapid and convenient mode of administration. KK Women s and Children s Hospital is the only public hospital catering specifically only for neonatal, paediatric, obstetrics and gynaecology care in Singapore. We believe that our list reached a significant proportion of doctors practicing in the relevant specialties by also including the Singapore General Hospital (the largest general public hospital in Singapore) as well as those in private practice via the medical societies and colleges. However, we cannot be sure that all the relevant doctors in Singapore were aware of the survey. Of note, participation from the private sector was low, with doctors in private practice comprising only 18% of respondents. We did not detect any obvious difference between public and private sector doctors but our study was not powered for such detailed analysis. However, we do not think awareness and knowledge levels would be lower amongst private practitioners as they also receive the same updates via and SMS from the Ministry of Health. We restricted the time period of the survey to two weeks, to minimise the possibility of official guidelines being altered during the survey period, as public health authorities are continuously reviewing and updating recommendations. During the survey period, the WHO updated its recommendations on sexual transmission of Zika virus, but these did not influence any of the questions in our survey. Our sample size also precluded robust comparison of knowledge between clinical specialties and medical designations, although this was not a primary objective. Despite this, our survey has enabled rapid identification of gaps in knowledge that can be acted upon to improve local as well as global preparedness for management and control of Zika virus disease. Page 9 of 15
10 Recommendations Our rapid assessment identified good levels of Zika virus disease knowledge among doctors in key clinical specialties of obstetrics and gynaecology, neonatology and paediatrics in Singapore. The findings provide a reference threshold in terms of knowledge level among doctors in settings with robust infrastructures to access information for a rapidly-evolving epidemic. Knowledge levels in lower-income countries with limited public health systems and access to information via the internet may be much lower. We have identified specific key areas for targeted improvements when communicating Zika virus disease knowledge to frontline doctors. We recommend that future guidelines emphasize clinical signs and symptoms which differentiate Zika virus disease from similar conditions such as dengue, particularly in countries with endemic dengue virus transmission. Similarly, greater emphasis in information sources on not using NSAIDS as a treatment option unless dengue has been excluded is also needed. There is an urgent requirement to improve doctor s knowledge on the need to advice at risk patients to practise safe sex or abstain from sexual intercourse for the duration of the pregnancy as well as the importance of ophthalmic evaluations in congenital Zika virus infection. In addition, there is still a need to educate doctors in key specialties regarding the appropriate use of Zika virus diagnostic tests and their current limitations, both to minimize the risk of misdiagnosis and to help patients make informed decisions. Acknowledgements We would like to thank Nur Lailati Mukaral, Dayana Eddy, Janet Kok, Ng Mor Jack and Deborah Low Wenli for administrative help with the survey. We are also grateful to our clinical colleagues for taking the time to participate in the survey. Author's contributions CFY, CCT and MLSF designed the study, oversaw the analysis and recruitment. CFY and CT wrote the first draft of the manuscript. VSR, JKYC, YHN, KCT, LKT provided inputs in recruitment and drafting the manuscript. Sources of funding No funding was obtained specifically for this study. JKYC received salary support from Singapore s National Medical Research Council, of the Ministry of Health (NMRC/CSA/043/2012) Competing interests All authors declare no competing interests. Page 10 of 15
11 References 1. Heymann DL, Hodgson A, Sall AA, Freedman DO, Staples JE, Althabe F, et al. Zika virus and microcephaly: why is this situation a PHEIC? Lancet (London, England) [Internet] Feb 20 [cited 2016 Jun 28];387(10020): Available from: 2. Brasil P, Pereira JP, Raja Gabaglia C, Damasceno L, Wakimoto M, Ribeiro Nogueira RM, et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro - Preliminary Report. N Engl J Med [Internet] Mar 4 [cited 2016 Jun 28]; Available from: 3. Paploski IAD, Prates APPB, Cardoso CW, Kikuti M, Silva MMO, Waller LA, et al. Time Lags between Exanthematous Illness Attributed to Zika Virus, Guillain-Barré Syndrome, and Microcephaly, Salvador, Brazil. Emerg Infect Dis [Internet] Aug 15 [cited 2016 Jun 28];22(8). Available from: 4. Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D, et al. Association between Zika virus and microcephaly in French Polynesia, : a retrospective study. Lancet [Internet]. Elsevier; 2016 May [cited 2016 Jun 28];387(10033): Available from: 5. Cao-Lormeau V-M, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet [Internet]. Elsevier; 2016 Apr [cited 2016 Jun 28];387(10027): Available from: 6. Yung CF, Thoon KC. Guillain-Barré Syndrome and Zika Virus: Estimating Attributable Risk to Inform Intensive Care Capacity Preparedness. Clin Infect Dis May 25. pii: ciw355. Available from: 7. WHO Zika situation report. WHO [Internet]. World Health Organization; 2016 [cited 2016 Jun 28]; Available from: 8. Yung CF, Chong CY, Yeo KT, et al. Zika Virus: An Evolving Public Health Threat. Ann Acad Med Singapore 2016; 45. Available at: 9. Fleming-Dutra KE, Nelson JM, Fischer M, Staples JE, Karwowski MP, Mead P, et al. Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection United States, February MMWR Morb Mortal Wkly Rep [Internet] Feb 19 [cited 2016 Jun 28];65(7):1 6. Available from: Rabe IB, Staples JE, Villanueva J, Hummel KB, Johnson JA, Rose L, et al. Interim Guidance for Interpretation of Zika Virus Antibody Test Results. MMWR Morb Mortal Wkly Rep [Internet] [cited 2016 Jun 28];65(21): Available from: Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika Virus and Birth Defects--Reviewing the Evidence for Causality. N Engl J Med [Internet] May 19 [cited 2016 Jun 28];374(20): Available from: National Environment Agency. Do the Mozzie Wipeout [Internet]. [cited 2016 Jun 28]. Available from: Page 11 of 15
12 Table 2: Responses to questions in a survey on Zika virus awareness among doctors (obstetrics and gynaecology, neonatology and paediatrics), Singapore 2016 (n = 110) Question n % Clinical Presentation, Diagnosis and Management Which of the following symptoms does Zika virus disease usually present with? Low-grade fever (<38.5 C) % High-grade fever ( 38.5 C) % Maculopapular rash % Conjunctivitis % Muscle/joint pain % Signs of bleeding/haemorrhage 6 5.5% Which of the following samples would you consider as your first choice for Zika virus diagnosis? Blood % Urine % Saliva 8 7.3% Which of the following samples would you consider as your second choice for Zika virus diagnosis? Blood % Urine % Saliva % Cerebrospinal fluid % Semen 7 6.4% A pregnant mother in her first trimester presents with fever that started two days ago. She had just come back from Brazil one week ago. Which of the following tests would you expect to be positive if she was infected with Zika virus? Zika virus serology 9 8.2% Zika virus PCR % Both % Neither 3 2.7% A pregnant mother in her second trimester presents with fever that started 8 days ago. She had just come back from Brazil 10 days ago. Which of the following tests would you expect to be positive if she was infected with Zika virus? Zika virus serology % Zika virus PCR % Both % Neither 6 5.5% What are the options for clinical management of Zika virus disease? Antivirals 9 8.2% Non-steroidal anti-inflammatory drugs % Pain relief medication % Fever relief medication % Fluid rehydration % Platelet transfusion 8 7.3% Which of the following conditions are linked to Zika infection? Congenital cardiac malformations 4 3.6% Microcephaly % Small for gestational age (SGA) % Guillain-Barré syndrome % Page 12 of 15
13 Transmission and Prevention Which types of mosquitoes are known to transmit Zika virus? Culex pipiens 6 5.5% Aedes aegypti % Aedes albopictus % Anopheles gambiae 4 3.6% Which of the following are additional documented modes of transmission for Zika virus? Saliva % Droplet spread % Sexual contact % Blood transfusion % Can Zika virus be transmitted to babies through breastfeeding? Yes % Clinical management of pregnant mothers potentially infected with Zika and infants with microcephaly Which of the following diagnostic tests are indicated for: infants with microcephaly or intracranial calcifications born to women who travelled to or resided in an area with Zika virus transmission while pregnant; OR infants born to mothers with positive or inconclusive test results for Zika virus infection? Test infant or umbilical cord serum for Zika infection % Test infant or umbilical cord serum for Dengue infection % Test infant or umbilical cord serum for Chikungunya infection % Collect infant CSF specifically to test for Zika infection % Collect infant CSF specifically to test for Dengue infection 8 7.3% Collect infant CSF specifically to test for Chikungunya infection 5 4.5% Which of the following clinical evaluation and laboratory tests should be considered for infants with possible congenital Zika virus infection? Cranial ultrasound % Ophthalmologic evaluation before discharge or within 1 month after birth % Ophthalmologic evaluation when 6 months old % Testing for infections such as syphilis, toxoplasmosis, rubella, and cytomegalovirus infection % Testing for infections such as lymphocytic choriomeningitis virus infection, and herpes simplex virus infections % Hearing evaluation before discharge or within 1 month after birth % Hearing evaluation when 6 months old % If pregnant women choose to travel to Zika-affected countries, what advice should be given to help reduce their risk of getting infected with Zika virus? Use insect repellent % Wear long sleeved clothing and trousers % Wear a face mask when going out % Stay in air-conditioned or screened-in room % Stay away from the beach/forest % Avoid going out at night to minimize risk of bites from mosquitoes that transmit Zika virus % None of the above 3 2.7% What is the current advice on sexual intercourse for a pregnant woman and her partner returning from a Zika virus-affected area and who may have been exposed to the virus? No need to abstain 8 7.3% Abstain or use condoms for 14 days % Abstain or use condoms for 28 days % Abstain or use condoms throughout pregn % Test semen for Zika virus 3 2.7% Page 13 of 15
14 Ministry of Health Requirements for Notification of Suspected Zika Virus Infection Zika virus is a notifiable disease in Singapore Yes, including suspected cases % Yes, confirmed cases only % Not notifiable 1 0.9% According to MOH Singapore guidelines (19 May 2016), which of the following fits the definition of Possible exposure to Zika virus? Correct definition given % Page 14 of 15
15 Figure 1: Domain-level scores among respondents to survey of Zika virus awareness, Singapore 2016 (n = 110) Figure 1 legend: Domain 1: Clinical Presentation, Diagnosis and Management; Domain 2: Transmission and Prevention; Domain 3: Clinical Management of Pregnant Mothers Potentially Infected with Zika and Infants with Microcephaly; Domain 4: Ministry of Health Requirements for Notification of Suspected Zika Virus Infection Page 15 of 15
Guidance for Investigation and Management of Zika Virus Infection
Guidance for Investigation and Management of Zika Virus Infection Update: February 11, 2016 Public Health Agency of Canada has issued recommendations from the Committee to Advise on Tropical Medicine and
More informationClinical Policy: Diagnostic Testing for Zika Virus Reference Number: CP.MP.111 Effective Date: 06/16
Clinical Policy: Diagnostic Testing for Zika Virus Reference Number: CP.MP.111 Effective Date: 06/16 Last Review Date: 05/16 Revision Log See Important Reminder at the end of this policy for important
More informationZIKA VIRUS OUTBREAK. JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016
ZIKA VIRUS OUTBREAK JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016 Zika time line 1947: 1 st isolated in rhesus monkey in Zika forest of Uganda 1 12/2013:
More informationEuropean Centre for Disease Prevention and Control. Zika virus disease
European Centre for Disease Prevention and Control Zika virus disease Stockholm, 19 February 2016 Background information Zika virus is a member of the Flaviviridae family and transmitted by mosquitoes
More informationZIKA UPDATE NOVEMBER Ministry of Health, Barbados
ZIKA UPDATE NOVEMBER 2016 Ministry of Health, Barbados Zika Virus Disease Objectives By the end of this presentation you should be able: To recount the track of the current global Zika virus epidemic To
More informationCDC Responds to ZIKA Zika 101
CDC Responds to ZIKA Zika 101 Updated April 29, 2016 What is Zika virus disease (Zika)? Disease spread primarily through the bite of an Aedes species mosquito infected with Zika virus. Many people infected
More informationWhat is Zika virus? What are the symptoms and complications of Zika virus infection? Are cases expected in Canada?
What is Zika virus? Zika Virus Update for Healthcare Professionals Updated June 22, 2016; italicized text indicates clarification of wording contained in previous versions. Zika virus is a Flavivirus transmitted
More informationA RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA
24 th December 2018 A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA BACKGROUND Zika virus infection, which erupted on a large scale in 2015-2016, has infected more than 1.5 million people.
More informationThis memo is intended to provide information to NC clinicians and laboratories regarding diagnosis, management and reporting of Zika virus infection.
May 18, 2016 (replaces version dated March 31, 2016) To: From: North Carolina Health Care Providers and Laboratories Megan Davies, MD, State Epidemiologist Scott Zimmerman, DrPH, MPH, HCLD (ABB), State
More informationZika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016
Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016 This interim guidance is the result of consultation
More informationFY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities
National Center on Birth Defects and Developmental Disabilities FY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities Sascha Chaney Associate
More informationZIKA VIRUS. John J. Russell MD May 27, 2016
John J. Russell MD May 27, 2016 HISTORY Discovered 1947 Zika Forest of Uganda in rhesus monkeys, thus the name Found in humans in Africa in 1952 Not considered a public health threat until outbreak in
More informationQuestions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection
1 of 5 01/02/2016 20:39 Questions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection Summary CDC has developed interim guidelines for healthcare providers in the United States
More informationZika Virus: The Olympics and Beyond
Zika Virus: The Olympics and Beyond Alice Pong, MD Pediatric Infectious Diseases Rady Children s Hospital-San Diego University of California, San Diego Disclosures I have no disclosures to report 1 Objectives
More informationSPECIALIZED FAMILY CARE Provider Training
SPECIALIZED FAMILY CARE Provider Training Category: Health Issue Title: Zika Virus Materials: Centers for Disease Control Fact Sheet on Zika Virus Goal: Specialized Family Care Provider to learn the risks,
More informationZika Virus What Every Woman Needs to Know
Zika Virus What Every Woman Needs to Know Carrie L. Byington, MD The Jean and Thomas McMullin Professor and Dean of Medicine Senior Vice President Health Science Center Vice Chancellor for Health Services
More informationAs suggested by one fellow student, please consider the CDC's "Final Rules for Control of Communicable Diseases: Interstate and Foreign
As suggested by one fellow student, please consider the CDC's "Final Rules for Control of Communicable Diseases: Interstate and Foreign http://www.cdc.gov/quarantine/ aboutlawsregulationsquarantineisolatio
More informationTown of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus
Aedes Zika Virus Information Sheet Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus The Zika Virus is a mosquito borne illness spread by the Aedes
More informationZika Virus Update. Partner Webinar 05/12/2016
Zika Virus Update Partner Webinar 05/12/2016 Today s presenters Patricia Quinlisk, MD, MPH, Medical Director /State Epidemiologist Ann Garvey, DVM, MPH, MA, State Public Health Veterinarian/ Deputy State
More informationCarol M. Smith, M.D., M.P.H. Commissioner of Health and Mental Health Ulster County Department of Health and Mental Health May 20, 2016
Carol M. Smith, M.D., M.P.H. Commissioner of Health and Mental Health Ulster County Department of Health and Mental Health May 20, 2016 Michael Hein County Executive Zika virus was first discovered in
More informationZika Virus. Robert Wittler, MD
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationZika Virus. Disclosure. Zika Virus 8/26/2016
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationZika 101 for Occupational Safety and Health Professionals
CDC Responds to ZIKA Zika 101 for Occupational Safety and Health Professionals CDR Jill M. Shugart, MSPH, REHS CDC/National Institute for Occupational Safety and Health Emergency Preparedness and Response
More informationFact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus assay. September 7, 2016
Dear Health Care Provider: Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus assay September 7, 2016 The U.S. Food and Drug Administration (FDA) has issued an Emergency
More informationEverything you ever wanted to know about Zika Virus Disease
Everything you ever wanted to know about Zika Virus Disease (in 14 slides) Jon Temte, MD/PhD University of Wisconsin School of Medicine and Public Health 28 January 2016 Zika Virus mosquito-borne flavivirus
More informationSexual & Reproductive Health in the Context of Zika Virus
Contents 1 The Zika Epidemic & its Impact on Health 2 Transmission, Pregnancy & Human Rights 3 GTR s Program & Public Policy Recommendations 4 GTR's Recommendations for Health Care Providers 5 GTR's Sexual
More informationZika Virus Identifying an Emerging Threat. Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services
Zika Virus Identifying an Emerging Threat Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services What is Zika Virus? Zika virus is a vector-borne disease
More informationZIKA VIRUS TESTING GUIDANCE, UPDATED 7/20/2016
Section 1: Which patients should be offered testing? SUMMARY OF CATEGORIES OF PATIENTS WHO SHOULD BE TESTED FOR ZIKA 1) Pregnant women who traveled to a Zika-affected area (see link to current list in
More informationZika virus: a new global threat for Dr Gina McAllister Clinical Scientist, Virology
Zika virus: a new global threat for 2016 Dr Gina McAllister Clinical Scientist, Virology Moritz U. G. Kraemer and others The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus
More informationZika in Texas. How to Prevent the Spread of the Zika Virus
Zika in Texas How to Prevent the Spread of the Zika Virus 1 Introduction 2 Zika in Texas 3 Overview of Zika Zika spreads primarily through the bite of an infected Aedes species mosquito. Can be spread
More informationZika Virus. Centers for Disease Control and Prevention
Centers for Disease Control and Prevention Zika Virus Ingrid Rabe Medical Epidemiologist Arboviral Diseases Branch Centers for Disease Control and Prevention February 1, 2016 Zika Virus Single stranded
More informationZIKA VIRUS. Causes, Symptoms, Treatment and Prevention
ZIKA VIRUS Causes, Symptoms, Treatment and Prevention Introduction Zika virus is spread to people through mosquito bites. The most common symptoms of Zika virus disease are fever, rash, joint pain, and
More informationWhat is Zika virus (Zika)?
Zika Virus Basics What is Zika virus (Zika)? Viral infection caused by the bite of an infected mosquito Linked to serious birth defects and other poor pregnancy outcomes in babies of mothers who were infected
More informationWhat s Lurking out there??????
What s Lurking out there?????? Dave Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene david.warshauer@slh.wisc.edu WISCONSIN STATE LABORATORY OF HYGIENE
More informationWelcome All. Western Australia Oncology Menopause Endometriosis New Mothers
Welcome All Western Australia ZIKA VIRUS What s the latest? Dr Clay Golledge COUNTRIES WITH ONGOING ZIKA CIRCULATION American Samoa Curacao Guyana Nicaragua Tonga Barbados Dominican Republic Haiti Panama
More informationGeographic distribution ZIKV
Shelley M. Wood, RN, BSN, CEN March 16, 2016 Geographic distribution ZIKV 1947 2007 http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2819875/ 1 Current Active Zika transmission WHO declared global health threat
More informationModule Three About Zika Virus: What is Known and Not Known
Module Three About Zika Virus: What is Known and Not Known HOUSEKEEPING For educational and quality improvement purposes, this TeleECHO Clinic will be recorded By participating in this clinic, you are
More informationZika Virus. Public Information Update/phone script. Date: March 28, 2016 Time: 11:00 a.m.
Zika Virus Public Information Update/phone script Date: March 28, 2016 Time: 11:00 a.m. ** Highlighted text indicates new, revised or updated information Note to operators: When people call asking questions
More informationZika virus infection Interim clinical guidance for Primary Care
Zika virus infection Interim clinical guidance for Primary Care Zika virus infection is a notifiable disease in Ireland under the Infectious Diseases (Amendment) Regulations 2016 (S.I.. 276 of 2016). All
More informationZIKA COLLABORATION MEETING: CLINICAL PERSPECTIVE. Julius L. Tonzel Vector-borne Diseases Epidemiologist Louisiana Office of Public Health
ZIKA COLLABORATION MEETING: CLINICAL PERSPECTIVE Julius L. Tonzel Vector-borne Diseases Epidemiologist Louisiana Office of Public Health DISCLOSURE STATEMENT The speakers, the speakers spouses, and the
More informationTHE ZIKA VIRUS. August 3, Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group
THE ZIKA VIRUS August 3, 2016 Sonia G. Pandit, MPH MBA Chief Executive Officer The Pandit Group sonia@thepanditgroup.com 443-990-1372 www.thepanditgroup.com What Makes Zika Unique? Viral disease (Flavi
More informationZIKA Jordan H. Perlow MD Banner University Medical Center Division of Maternal Fetal Medicine Phoenix Perinatal Asoociates
ZIKA Jordan H. Perlow MD Banner University Medical Center Division of Maternal Fetal Medicine Phoenix Perinatal Asoociates Disclosures I have no relevant financial relationships to disclose or conflicts
More informationZika Virus: Epidemiology and Preparedness NH Emergency Preparedness Conference June 9, 2016
Zika Virus: Epidemiology and Preparedness NH Emergency Preparedness Conference June 9, 2016 Abigail Mathewson, DVM, MPH Surveillance Epidemiology Program Manager State Public Health Veterinarian Abigail.mathewson@dhhs.nh.gov
More informationPresentation Overview
Presentation Overview Characteristics of Zika virus Characteristics of Zika virus infection Epidemiology and outbreaks Vector and transmission Clinical symptoms Diagnosis and testing Treatment and prevention
More informationZika Virus. Frequently Asked Questions: Zika Virus and Pregnancy Version
Zika Virus Frequently Asked Questions: Zika Virus and Pregnancy Version What is Zika? Zika is a viral infection that usually causes a mild illness that typically lasts between 2 and 7 days. 80% of people
More informationFight the Bite Zika Virus Webinar District of Columbia Department of Health
Fight the Bite Zika Virus Webinar District of Columbia Department of Health August 2016 Zika Virus Background and Tracking in Washington, DC, and Surrounding States Andrew Hennenfent, DVM, MPH DC Department
More informationZika Virus and Control Efforts in Arizona
Zika Virus and Control Efforts in Arizona Irene Ruberto, MPH, PhD Epidemiologist Office of Infectious Disease Services Arizona Department of Health Services November 10, 2016 Goal by Humbletree (cc by-nc
More informationZika Virus Guidance for Medical Providers. Denise Smith, PHN, MPA Director of Disease Control Kern County Public Health Services Department
Zika Virus Guidance for Medical Providers Denise Smith, PHN, MPA Director of Disease Control Kern County Public Health Services Department Kern Perinatal Symposium March 3, 2017 CME DISCLOSURE The Planners,
More informationZika Virus in the Primary Care Setting
Zika Virus in the Primary Care Setting Monica McArthur, MD PhD Assistant Professor of Pediatrics Center for Vaccine Development University of Maryland School of Medicine Maryland Chapter ACP Meeting 17
More informationOutbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016
Outbreaks of Zika Virus: What Do We Know? Presented by Dr Jonathan Darbro Mosquito Control Lab, QIMR Berhgofer 15 September 2016 Overview History Distribution Modes of Transmission Symptoms Some Causal
More information*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a
*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a GDPH epidemiologist 404-657-2588, 8-5 pm M-F for current
More informationZika Preparedness: Lessons for the U.S. Public Health System
Zika Preparedness: Lessons for the U.S. Public Health System Jeffrey Duchin, MD Health Officer, Public Health - Seattle & King County Professor in Medicine, Division of Infectious Diseases Adjunct Professor,
More informationZika Virus. ZIKA VIRUS & PREGNANCY Stephen Champlin, M.D. FLAVIVIRIDAE VIRUS SPECTRUM. Virus family Flaviviridae
ZIKA VIRUS & PREGNANCY Stephen Champlin, M.D. Zika Virus Virus family Flaviviridae Positive sense, single-stranded RNA virus FLAVIVIRIDAE VIRUS SPECTRUM Arbovirus - spread by arthropods to mammals Flaviviridae
More informationPublic Health Image Library. CDC/ Cynthia Goldsmith. Image #
Zika Virus Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar,
More informationZika Virus Update. Florida Department of Health (DOH) Mark Lander. June 16, Florida Department of Health in Columbia County
Zika Virus Update Florida Department of Health (DOH) Mark Lander June 16, 2016 Florida Department of Health in Columbia County 1 Zika Virus Originally identified in Africa and Southeast Asia First identified
More informationWhen infections go viral Zika Virus
When infections go viral Zika Virus John Fangman, MD Associate Professor of Medicine (Infectious Diseases) Senior Medical Director of Ambulatory, Medical College Physicians Medical College of Wisconsin
More informationWrapping Our Heads Around the Outbreak
Wrapping Our Heads Around the Outbreak An Update on the Zika Virus P. Zach White, PharmD PGY1 Pharmacy Resident Mayo Eugenio Litta Children s Hospital Pharmacy Grand Rounds June 7, 2016 2015 MFMER slide-1
More informationGeneral Description. Significance
General Description The Zika virus is a member of the Flavivirus family, and is a small, enveloped virus (easy to kill with a hospital disinfectant). Zika virus is an emerging mosquito-borne virus that
More informationEstablishing base levels of microcephaly in Brazil prior to the arrival of Zika viral illnesses
DISCLAIMER This paper was submitted to the Bulletin of the World Health Organization and was posted to the Zika open site, according to the protocol for public health emergencies for international concern
More informationZika Virus Dr Conor Doherty
Zika Virus Dr Conor Doherty Zika Virus Single stranded RNA enveloped icosahedral virus Flavivirus (e.g. dengue, yellow feve er) First described in Zika forest in Uganda in 1947 Initial enzootic monkey
More information3/24/2017. CDC S Response to Zika ZIKA 101. Updated February 2, 2017 INTRODUCTION
CDC S Response to Zika ZIKA 101 Updated February 2, 2017 INTRODUCTION 1 What is Zika? Zika virus is spread to people primarily through the bite of an infected Aedes species mosquito (Ae. aegypti and Ae.
More informationUpdates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016
Updates in Infectious Diseases Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016 Disclosures No financial relationships or affiliations to disclose Overview Activity Pre-Test
More informationZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa
ZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa 18 th April 1947; Rhesus macaque (no 766) with fever Filtrable transmissable agent The absence
More informationZIKA VIRUS. Facts & Figures
ZIKA VIRUS Facts & Figures ISSUED FEBRUARY 20, 2017 Over the past year, Zika Virus has become a signifi cant point of concern in our communities. As with any emergent illness or disease, it is important
More informationWhat You Need to Know ZIKA VIRUS
What You Need to Know ZIKA VIRUS What is Zika Virus? Zika virus is a flavivirus related to dengue, West Nile, yellow fever and Japanese encephalitis Zika virus first identified in 1947 and named for the
More informationZika Virus Update for Emergency Care Providers
Zika Virus Update for Emergency Care Providers What is this Zika Virus? Jeff Doerr Epidemiologist Southeastern Idaho Public Health Zika Virus Single stranded RNA virus Genus Flavivirus, Family Flaviviridae
More informationFigure 1: Suspected and confirmed Zika virus cases reported by countries and territories in the Americas, by epidemiological week (EW)
Zika - Epidemiological Update 17 March 2016 Zika virus Incidence and trends Available data reported suggests a downward trend in reporting of Zika virus cases in the Region of the Americas (Figure 1).
More informationCDC An Overview for State and Territorial Leaders
Centers for Disease Control and Prevention CDC An Overview for State and Territorial Leaders Matthew Penn, JD, MLIS Director, Public Health Law Program Office for State, Tribal, Local and Territorial Support
More informationZika Virus Response Planning: Interim Guidance for District and School Administrators in the Continental United States and Hawaii
Zika Virus Response Planning: Interim Guidance for District and School Administrators in the Continental United States and Hawaii Summary What is already known about this topic? Zika virus is transmitted
More informationNorth Carolina Department of Health and Human Services Division of Public Health
North Carolina Department of Health and Human Services Division of Public Health Pat McCrory Governor February 8, 2016 (replaces version dated January 28, 2016) Richard O. Brajer Secretary Daniel Staley
More informationZika: Deet, There It Is. Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS
Zika: Deet, There It Is Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS Disclosure I have no financial disclosures or conflicts of interest Lessons from Rubella At peak of rubella epidemic
More informationCenters for Disease Control and Prevention Zika Virus in Pregnancy What Midwives Need To Know
Centers for Disease Control and Prevention Zika Virus in Pregnancy What Midwives Need To Know Margaret A. Lampe, RN, MPH Pregnancy and Birth Defects Surveillance Team Zika Virus Emergency Response U.S.
More informationWaiting in the Wings: Emergence, Impact and Control of Mosquito-Borne Viruses
International Center for Enterprise Preparedness (InterCEP) Waiting in the Wings: Emergence, Impact and Control of Mosquito-Borne Viruses Web Forum On April 14, 2016, Kathryn A. Hanley, Professor in the
More informationAlberta Health Public Health Notifiable Disease Management Guidelines March 2017
Public Health Notifiable Disease Management Guidelines March 2017 Zika Virus Revision Dates Case Definition Reporting Requirements Epidemiology/Public Health Management March 2017 March 2017 March 2017
More informationThe problem with TORCH screening
: Beyond TORCHeS TORCH or STORCH-a helpful mnemonic? Toxoplasma Other Rubella CMV HSV (HIV) Syphilis 3 The problem with TORCH screening TORCH-first proposed by Nahmias et.al. (Pediatr Res 1971) Toxo, Rubella,
More informationZika Virus and Prevention in Mississippi
Mississippi State Department of Health Mississippi Morbidity Report Volume 32, Number 1 July 2016 Background: Zika Virus and Prevention in Mississippi Key Messages: Zika virus infection during pregnancy
More informationZika. Nicole Evert, MS Zoonosis Control Branch Department of State Health Services Austin, Texas
Zika Nicole Evert, MS Zoonosis Control Branch Department of State Health Services Austin, Texas Family Flaviviridae, genus Flavivirus Vectors: Aedes aegypti and Aedes albopictus Maintained in a human-mosquito-human
More informationZika Virus. Maternal & Fetal Effects. John P. Elliott, MD Medical Director, Valley Perinatal Services Phoenix, Arizona
Zika Virus Maternal & Fetal Effects John P. Elliott, MD Medical Director, Valley Perinatal Services Phoenix, Arizona Objective of Presentation Sneeka Peeka at Zika Disclosure I have nothing to disclose
More informationEpidemiology and entomology of the Zika virus outbreak
Epidemiology and entomology of the Zika virus outbreak M A T T H E W B A Y L I S I N S T I T U T E O F I N F E C T I O N A N D G L O B A L H E A L T H U N I V E R S I T Y O F L I V E R P O O L Zika in
More informationZika Update. PSSNY 2016 Annual Convention June 25, Suzanna Gim, PharmD, MPH
Zika Update PSSNY 2016 Annual Convention June 25, 2016 Suzanna Gim, PharmD, MPH Email: suzannagim@gmail.com Learning Objectives Describe the epidemiology and prevalence of Zika virus disease Identify the
More informationZika Virus: What We Know and Don t Know Meg Fisher, MD Medical Director. Disclosures. Objectives
Zika Virus: What We Know and Don t Know Meg Fisher, MD Medical Director Disclosures I have no financial disclosures. I do not plan to discuss off label uses of medications. Objectives Discuss the epidemiology
More informationZIKA VIRUS WHAT IS THE SITUATION IN SINGAPORE? 6 September 2016
6 September 2016 ZIKA VIRUS Zika virus was first discovered in 1947 and is named after the Zika Forest in Uganda. In 1952, the first human cases of Zika were detected and since then, outbreaks of Zika
More informationMathematical Modelling the Spread of Zika and Microcephaly in Brazil.
Proceedings of the 17th International Conference on Computational and Mathematical Methods in Science and Engineering, CMMSE 2017 4 8 July, 2017. Mathematical Modelling the Spread of Zika and Microcephaly
More informationRelevant Communicable Diseases in HCT/Ps
Relevant Communicable Diseases in HCT/Ps Phyllis I. Warkentin, MD Professor of Pathology and Pediatrics University of Nebraska Medical Center FACT Chief Medical Officer Relevant Communicable Diseases in
More informationMosquito Threats in LA County West Nile virus & Zika
Mosquito Threats in LA County West Nile virus & Zika The District at a Glance An independent special district formed under authority of the CA State Health and Safety Code Formed in 1952 and governed by
More informationPublic Views of the Zika Virus Outbreak
Public Views of the Zika Virus Outbreak Technical Assistance for National Public Health Information Coalition Harvard Opinion Research Program Harvard T.H. Chan School of Public Health Harvard T.H. Chan
More informationZIKA VIRUS. Facts & Figures
ZIKA VIRUS Facts & Figures ISSUED APRIL 27, 2017 Zika Virus has become a signifi cant point of concern in our communities. As with any illness or disease, it is important to know the facts, so you can
More informationZika Virus. Lee Green Vector-Borne Epidemiologist Indiana State Department of Health. April 13, 2016
Zika Virus Lee Green Vector-Borne Epidemiologist Indiana State Department of Health April 13, 2016 What Is It? Flavivirus WNV Dengue St. Louis Encephalitis Yellow Fever Tick Borne Encephalitis Single stranded
More informationZika: Updates and Lessons Learned for Primary Care Clinicians
Zika: Updates and Lessons Learned for Primary Care Clinicians Kirsten Salmeen, MD Assistant Professor UCSF Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have no financial disclosures.
More informationInterim Guidelines for Pregnant Women During a Zika Virus Outbreak United States, 2016
1 of 7 01/02/2016 20:32 Interim Guidelines for Pregnant Women During a Zika Virus Outbreak United States, 2016 Weekly / January 22, 2016 / 65(2);30 33 On January 19, 2016, this report was posted as an
More informationZika Virus. Report to the Standing Committee on Health. Dr. Graham Sher Chief Executive Officer, Canadian Blood Services
Dr. Graham Sher Chief Executive Officer, Services Dr. Dana Devine Chief Medical and Scientific Officer, Services Services Services is an arm s-length organization within the larger health-care system of
More informationZika and the Threat to Pregnant Women and Their Babies: How Your Local Health Departments Works to Keep Communities Safe
Zika and the Threat to Pregnant Women and Their Babies: How Your Local Health Departments Works to Keep Communities Safe Q&A with Dr. Oscar Alleyne, Senior Advisor for Public Health Programs National Association
More informationClinical Policy Title: Zika virus
Clinical Policy Title: Zika virus Clinical Policy Number: 17.01.04 Effective Date: October 1, 2016 Initial Review Date: May 18, 2016 Most Recent Review Date: May 18, 2016 Next Review Date: May 2017 Policy
More informationZika Virus: Impact, Issues and Updates
Zika Virus: Impact, Issues and Updates Moderator: Chris Campanile, MD, Family Physician at Coastal Hillside Family Medicine, Pawtucket, RI, NE QIN-QIO Consultant Clinical Director, Healthcentric Advisors
More informationPresenter Information
Presenter Information. BLUF BOTTOM LINE: - If you live in or travel to an area with ongoing Zika virus transmission, take precautions to minimize risk. - The risk of Zika infection is reduced by taking
More informationZika virus: clinical and epidemiological features
Zika virus: clinical and epidemiological features Dominic Dwyer Medical Virologist, Westmead Hospital Director, ICPMR and Pathology West NSW Health Pathology dominic.dwyer@sydney.edu.au, Zika virus Flavivirus
More informationZika Virus Communication Media Talking Points
Zika Virus Communication Media Talking Points Benjamin Haynes Senior Press Officer, News Media Branch, CDC Department of Health and Human Services Centers for Disease Control and Prevention Media Talking
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: de Oliveira WK, Carmo EH, Henriques CM, et al. Zika virus infection
More informationZika virus and severe microcephaly in Canada
Zika virus and severe microcephaly in Canada Jenna Coles, MSc, Public Health Agency of Canada, Ottawa Chantal Nelson, PhD, Public Health Agency of Canada, Ottawa Alex Demarsh, PhD, Public Health Agency
More informationSave the Children s Zika Virus Response: Addressing Education and Personal Protection Needs in the Americas Request for Support
Save the Children s Zika response strategy in 11 countries in the Americas focuses on increasing awareness of the virus and its prevention, in part by reaching women such as this Guatemalan mother through
More information